Switching within the class of IL‐17 inhibitors for the treatment of plaque psoriasis: A real‐world retrospective study

Saved in:
Bibliographic Details
Published inAustralasian journal of dermatology Vol. 66; no. 2; pp. 101 - 104
Main Authors Koumprentziotis, Ioannis‐Alexios, Rompoti, Natalia, Stefanaki, Irene, Vavouli, Charitomeni, Papoutsaki, Marina, Politou, Maria, Stratigos, Alexander, Nicolaidou, Electra
Format Journal Article
LanguageEnglish
Published Australia Wiley Subscription Services, Inc 01.03.2025
John Wiley and Sons Inc
Subjects
Online AccessGet full text
ISSN0004-8380
1440-0960
1440-0960
DOI10.1111/ajd.14396

Cover

Author Papoutsaki, Marina
Rompoti, Natalia
Politou, Maria
Koumprentziotis, Ioannis‐Alexios
Nicolaidou, Electra
Vavouli, Charitomeni
Stefanaki, Irene
Stratigos, Alexander
AuthorAffiliation 1 1st Department of Dermatology‐Venereology, Medical School National and Kapodistrian University of Athens, "A. Sygros" Hospital for Skin and Venereal Diseases Athens Greece
AuthorAffiliation_xml – name: 1 1st Department of Dermatology‐Venereology, Medical School National and Kapodistrian University of Athens, "A. Sygros" Hospital for Skin and Venereal Diseases Athens Greece
Author_xml – sequence: 1
  givenname: Ioannis‐Alexios
  orcidid: 0000-0002-1156-7139
  surname: Koumprentziotis
  fullname: Koumprentziotis, Ioannis‐Alexios
  email: giannhskmpr@gmail.com
  organization: National and Kapodistrian University of Athens, "A. Sygros" Hospital for Skin and Venereal Diseases
– sequence: 2
  givenname: Natalia
  surname: Rompoti
  fullname: Rompoti, Natalia
  organization: National and Kapodistrian University of Athens, "A. Sygros" Hospital for Skin and Venereal Diseases
– sequence: 3
  givenname: Irene
  surname: Stefanaki
  fullname: Stefanaki, Irene
  organization: National and Kapodistrian University of Athens, "A. Sygros" Hospital for Skin and Venereal Diseases
– sequence: 4
  givenname: Charitomeni
  surname: Vavouli
  fullname: Vavouli, Charitomeni
  organization: National and Kapodistrian University of Athens, "A. Sygros" Hospital for Skin and Venereal Diseases
– sequence: 5
  givenname: Marina
  surname: Papoutsaki
  fullname: Papoutsaki, Marina
  organization: National and Kapodistrian University of Athens, "A. Sygros" Hospital for Skin and Venereal Diseases
– sequence: 6
  givenname: Maria
  surname: Politou
  fullname: Politou, Maria
  organization: National and Kapodistrian University of Athens, "A. Sygros" Hospital for Skin and Venereal Diseases
– sequence: 7
  givenname: Alexander
  surname: Stratigos
  fullname: Stratigos, Alexander
  organization: National and Kapodistrian University of Athens, "A. Sygros" Hospital for Skin and Venereal Diseases
– sequence: 8
  givenname: Electra
  surname: Nicolaidou
  fullname: Nicolaidou, Electra
  organization: National and Kapodistrian University of Athens, "A. Sygros" Hospital for Skin and Venereal Diseases
BackLink https://www.ncbi.nlm.nih.gov/pubmed/39665153$$D View this record in MEDLINE/PubMed
BookMark eNp9kc1u1DAUhS1URKeFBS-ALLEBpLT2xHYSNmhU_opGYgGsLSe56XjkiVPb6Wi66iPwjDwJd5ryK4E319b97tG5x0fkoPc9EPKYsxOO59Ss2xMu8krdIzMuBMtYpdgBmTHGRFbmJTskRzGuGeM5l_IBOURUSS7zGbn-tLWpWdn-guIFK00roI0zMVLf0fPlt5uvvKC2X9naJh8i7Xy4ZVIAkzbQpz03OHM5Ah2iD9ZEG1_SBcW-w-mtD67FRwo-DtAkewU0prHdPST3O-MiPLqrx-TL2zefz95ny4_vzs8Wy6wRTKhMCs5lbQphZCWBqRqK_XpFLVlRqApA5rzmxkAHikFjeCOFUFCamvO2K6v8mLyYdMd-MLutcU4PwW5M2GnO9D5AjQHq2wARfjXBw1hvoG1wv2B-DXhj9Z-d3q70hb9CnbIqeTFHhWd3CsFjJjHpjY0NOGd68GPUORcYvsiVQPTpX-jaj6HHMJAq1HyuKrb3_-R3Sz-9_PhEBJ5PQIMRxwDdf_c7nditdbD7N6gXH15PE98BYhq-Cg
Cites_doi 10.1111/jdv.16202
10.1007/s00403‐019‐01907‐y
10.1111/jdv.18381
10.1111/jdv.19682
10.1111/jdv.15100
10.1016/j.jaad.2020.07.085
10.1111/dth.15772
10.1093/bjd/ljac089
10.1007/s40261‐017‐0603‐3
10.1111/jdv.18825
ContentType Journal Article
Copyright 2024 The Author(s). published by John Wiley & Sons Australia, Ltd on behalf of Australasian College of Dermatologists.
2024. This article is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: 2024 The Author(s). published by John Wiley & Sons Australia, Ltd on behalf of Australasian College of Dermatologists.
– notice: 2024. This article is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID 24P
AAYXX
CITATION
NPM
7T5
H94
K9.
NAPCQ
7X8
5PM
ADTOC
UNPAY
DOI 10.1111/ajd.14396
DatabaseName Wiley Online Library Open Access
CrossRef
PubMed
Immunology Abstracts
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
MEDLINE - Academic
PubMed Central (Full Participant titles)
Unpaywall for CDI: Periodical Content
Unpaywall
DatabaseTitle CrossRef
PubMed
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
Immunology Abstracts
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: 24P
  name: Wiley Online Library Open Access
  url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html
  sourceTypes: Publisher
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: UNPAY
  name: Unpaywall
  url: https://proxy.k.utb.cz/login?url=https://unpaywall.org/
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
DocumentTitleAlternate IL‐17 intraclass switch in psoriasis
EISSN 1440-0960
EndPage 104
ExternalDocumentID 10.1111/ajd.14396
PMC11898172
39665153
10_1111_ajd_14396
AJD14396
Genre shortCommunication
Journal Article
GroupedDBID ---
.3N
.GA
.GJ
.Y3
05W
0R~
10A
1OB
1OC
23N
24P
31~
33P
36B
3O-
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5HH
5LA
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AAHQN
AAIPD
AAMNL
AANHP
AANLZ
AAONW
AASGY
AAXRX
AAYCA
AAZKR
ABCQN
ABCUV
ABDBF
ABEML
ABJNI
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFS
ACGOF
ACMXC
ACPOU
ACPRK
ACRPL
ACSCC
ACUHS
ACXBN
ACXQS
ACYXJ
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADNMO
ADOZA
ADXAS
ADZMN
ADZOD
AEEZP
AEIGN
AEIMD
AENEX
AEQDE
AEUYR
AFBPY
AFEBI
AFFPM
AFGKR
AFWVQ
AFZJQ
AHBTC
AHEFC
AIACR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ARTTT
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CAG
COF
CS3
CYRXZ
D-6
D-7
D-E
D-F
DC6
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
EAD
EAP
EAS
EAZ
EBC
EBD
EBS
EJD
EMB
EMK
EMOBN
EPT
ESX
EX3
F00
F01
F04
F5P
FEDTE
FUBAC
G-S
G.N
GODZA
H.X
HF~
HGLYW
HVGLF
HZI
HZ~
IHE
IX1
J0M
J5H
K48
KBYEO
KTM
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
O66
O9-
OIG
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PALCI
Q.N
Q11
QB0
Q~Q
R.K
RIWAO
RJQFR
ROL
RX1
SAMSI
SUPJJ
SV3
TEORI
TUS
UB1
W8V
W99
WBKPD
WHWMO
WIH
WIJ
WIK
WOHZO
WOQ
WOW
WQJ
WVDHM
WXI
WXSBR
XG1
ZGI
ZXP
ZZTAW
~IA
~WT
AAMMB
AAYXX
AEFGJ
AEYWJ
AGHNM
AGQPQ
AGXDD
AGYGG
AIDQK
AIDYY
CITATION
NPM
7T5
H94
K9.
NAPCQ
7X8
5PM
ADTOC
UNPAY
ID FETCH-LOGICAL-c4046-54115ba74a595e06be709607b507769ee531b1aaefe60eca1c5446e8ab11df893
IEDL.DBID UNPAY
ISSN 0004-8380
1440-0960
IngestDate Sun Oct 26 04:14:24 EDT 2025
Thu Aug 21 18:34:12 EDT 2025
Thu Oct 02 07:37:03 EDT 2025
Tue Oct 07 07:06:24 EDT 2025
Thu Apr 03 06:59:40 EDT 2025
Wed Oct 01 06:40:34 EDT 2025
Wed Mar 12 09:40:33 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords Il‐17 inhibitors
intraclass switch
biologics
bimekizumab
psoriasis
Language English
License Attribution
This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
cc-by
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4046-54115ba74a595e06be709607b507769ee531b1aaefe60eca1c5446e8ab11df893
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0002-1156-7139
OpenAccessLink https://proxy.k.utb.cz/login?url=https://doi.org/10.1111/ajd.14396
PMID 39665153
PQID 3176226909
PQPubID 2045191
PageCount 4
ParticipantIDs unpaywall_primary_10_1111_ajd_14396
pubmedcentral_primary_oai_pubmedcentral_nih_gov_11898172
proquest_miscellaneous_3146654364
proquest_journals_3176226909
pubmed_primary_39665153
crossref_primary_10_1111_ajd_14396
wiley_primary_10_1111_ajd_14396_AJD14396
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate March 2025
PublicationDateYYYYMMDD 2025-03-01
PublicationDate_xml – month: 03
  year: 2025
  text: March 2025
PublicationDecade 2020
PublicationPlace Australia
PublicationPlace_xml – name: Australia
– name: Boronia Park
– name: Hoboken
PublicationTitle Australasian journal of dermatology
PublicationTitleAlternate Australas J Dermatol
PublicationYear 2025
Publisher Wiley Subscription Services, Inc
John Wiley and Sons Inc
Publisher_xml – name: Wiley Subscription Services, Inc
– name: John Wiley and Sons Inc
References 2022; 35
2019; 311
2022; 36
2020; 34
2019; 33
2024; 38
2023; 37
2021; 84
2018; 38
2023; 188
e_1_2_2_4_1
e_1_2_2_5_1
e_1_2_2_6_1
e_1_2_2_7_1
e_1_2_2_11_1
e_1_2_2_10_1
e_1_2_2_2_1
e_1_2_2_3_1
e_1_2_2_9_1
e_1_2_2_8_1
References_xml – volume: 34
  start-page: 1240
  issue: 6
  year: 2020
  end-page: 1247
  article-title: Real‐world data from a single Greek centre on the use of secukinumab in plaque psoriasis: effectiveness, safety, drug survival, and identification of patients that sustain optimal response
  publication-title: J Eur Acad Dermatol Venereol
– volume: 188
  start-page: 330
  issue: 3
  year: 2023
  end-page: 340
  article-title: Bimekizumab efficacy and safety in patients with moderate‐to‐severe plaque psoriasis who switched from adalimumab, ustekinumab or secukinumab: results from phase III/IIIb trials
  publication-title: Br J Dermatol
– volume: 33
  start-page: e7
  issue: 1
  year: 2019
  end-page: e8
  article-title: Biologic switching between interleukin 17A antagonists secukinumab and ixekizumab: a 12‐week, multicenter, retrospective study
  publication-title: J Eur Acad Dermatol Venereol
– volume: 84
  start-page: 130
  issue: 1
  year: 2021
  end-page: 138
  article-title: Efficacy of a second interleukin 17 inhibitor in patients with psoriasis: a systematic review and meta‐analysis
  publication-title: J Am Acad Dermatol
– volume: 311
  start-page: 421
  issue: 5
  year: 2019
  end-page: 424
  article-title: Successful intra‐class switching among IL‐17 antagonists: a multicentre, multinational, retrospective study
  publication-title: Arch Dermatol Res
– volume: 35
  issue: 10
  year: 2022
  article-title: Efficacy of switches within the class of IL‐17 inhibitors: an analysis of data from the Czech nationwide registry of psoriatic patients receiving biological/targeted therapy (BIOREP)
  publication-title: Dermatol Ther
– volume: 37
  start-page: 689
  issue: 4
  year: 2023
  end-page: 697
  article-title: Brodalumab in plaque psoriasis: real‐world data on effectiveness, safety and clinical predictive factors of initial response and drug survival over a period of 104 weeks
  publication-title: J Eur Acad Dermatol Venereol
– volume: 38
  start-page: 191
  issue: 3
  year: 2018
  end-page: 199
  article-title: A review of switching biologic agents in the treatment of moderate‐to‐severe plaque psoriasis
  publication-title: Clin Drug Investig
– volume: 36
  start-page: e952
  issue: 11
  year: 2022
  end-page: e953
  article-title: Real‐life intraclass switch among IL‐17 inhibitors in psoriasis: results from a single‐centre, 24‐week, retrospective study
  publication-title: J Eur Acad Dermatol Venereol
– volume: 38
  start-page: 568
  issue: 3
  year: 2024
  end-page: 575
  article-title: Drug survival, effectiveness and safety of ixekizumab for moderate‐to‐severe psoriasis up to 5 years
  publication-title: J Eur Acad Dermatol Venereol
– ident: e_1_2_2_8_1
  doi: 10.1111/jdv.16202
– ident: e_1_2_2_3_1
  doi: 10.1007/s00403‐019‐01907‐y
– ident: e_1_2_2_5_1
  doi: 10.1111/jdv.18381
– ident: e_1_2_2_9_1
  doi: 10.1111/jdv.19682
– ident: e_1_2_2_7_1
  doi: 10.1111/jdv.15100
– ident: e_1_2_2_6_1
  doi: 10.1016/j.jaad.2020.07.085
– ident: e_1_2_2_4_1
  doi: 10.1111/dth.15772
– ident: e_1_2_2_11_1
  doi: 10.1093/bjd/ljac089
– ident: e_1_2_2_2_1
  doi: 10.1007/s40261‐017‐0603‐3
– ident: e_1_2_2_10_1
  doi: 10.1111/jdv.18825
SSID ssj0013155
Score 2.3761222
SourceID unpaywall
pubmedcentral
proquest
pubmed
crossref
wiley
SourceType Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 101
SubjectTerms bimekizumab
biologics
Il‐17 inhibitors
intraclass switch
Psoriasis
Research Letter
SummonAdditionalLinks – databaseName: Wiley Online Library Open Access
  dbid: 24P
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lb9QwEB6VIgEXVF4lUJB5HLhESja2E8Np1VKVChASVOotspOJGrRKVs2uKjjxE_iN_SXMOA9YVSBuiTx2rHwe-xt7PAPwstJEWmOUoaaJL5ScyN0VZhY6rDKjbME2AHtbfNRHJ_L4VJ1uwZvxLkwfH2LacGPN8PM1K7h13R9Kbr-WpOaJ0dfgekw8hof3TH76fYQQqz59QSTDLMmiIawQu_FMVTcXoysM86qj5M11s7TfLuxisUlm_Wp0uAO3Bxop5j3ud2ALm7tw48NwUH4Pvn--qFfeTVLwTmvdCCJ6omCqLNpKvHt_-eNnnIq6OatdzQl3BJFXLzN5nrPccmGpr2LZtTROu7p7LeaCyhdU24dapZfVeTve1hQ-Vu19ODl8-2X_KBzSLISFJOs4VJJYobOptMoojLTDlO2a1CkO9WMQSU1dbC1WqCMsbFwosiExsy6OS0I0eQDbTdvgQxCz0qFCJI6HpUwqadKiJEZSSpVI1NYE8Hz83_myj6aRj1YIgZJ7UALYG5HIB4XqcqI5mpiiiaiNZ1MxqQKfb9gG2zXLSM6lnGgZwG4P3PQVapeTvicBZBuQTgIcZnuzpKnPfLhtMsFMRjwvgBcT-v_q_Ss_Lv4ukc-PD_zDo_8XfQy3Zpx42Du_7cH26nyNT4gNrdxTP-p_AZkrB9U
  priority: 102
  providerName: Wiley-Blackwell
Title Switching within the class of IL‐17 inhibitors for the treatment of plaque psoriasis: A real‐world retrospective study
URI https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fajd.14396
https://www.ncbi.nlm.nih.gov/pubmed/39665153
https://www.proquest.com/docview/3176226909
https://www.proquest.com/docview/3146654364
https://pubmed.ncbi.nlm.nih.gov/PMC11898172
https://doi.org/10.1111/ajd.14396
UnpaywallVersion publishedVersion
Volume 66
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVWIB
  databaseName: Wiley Online Library - Core collection (SURFmarket)
  issn: 0004-8380
  databaseCode: DR2
  dateStart: 19970101
  customDbUrl:
  isFulltext: true
  eissn: 1440-0960
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0013155
  providerName: Wiley-Blackwell
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjZ3NbtQwEIBH7VaCXvinDZTKBQ5cUm0S20m4rShVqaCqgJXKKbKTiRq6SlbdrCp64hH6jH0Sxs4PhIqKyyorT5yNPZN8sx7PALzOJUGrh9yV9OBzuSnkrtPYdzXmUSxUanwAE21xJA-m_PBEnKzATrcX5s_1exNxo75nZMxBLFdhTQrC7RGsTY-OJ98arOVuFNjqaHaN0uB4mz1ocO7wnXMDJG_GQ95dlnP140LNZkNmtS-d_fu_t-40sSZnu8ta76aXf2VyvPV-HsC9FjnZpNGRh7CC5SO486ldVH8Ml18uitqGVDLzr2xRMoJClhqsZlXOPny8_nnlhawoTwtdmOI8jEDXyvRR6kZuPlN0w2y-qEinF8XiLZswap_R2TYtK32pz6tuZyezeW2fwHT__dd3B25bksFNOXnSruBEkFqFXIlY4FhqDM2gh1qYtEAxIpm09pTCHOUYU-WlgvxNjJT2vIxmP3gKo7IqcROYn2kUiMSDmPEg53GYZkQvGRcBR6liB152k5bMm8wbSeex0CgmdhQd2OqmM2mNb5EQEkmiynhMfez0zWQ2Zi1ElVgtjQw3dZcDyR3YaGa_vwr1awrEBw5EA73oBUxK7mFLWZza1NzkrsURMaEDr3oVuu3Xv7HK9W-JZHK4Zw-e_VeHz2HdN_WJbYzcFozq8yW-IGiq9Tas-vyYPvc--9utCf0CI_kWHA
linkProvider Unpaywall
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lb9QwEB6VIlEuiGcJtGAeBy6Rko3tJFUvK0q1LdsKiVbqLbKTiRq0SlbdXVVw4ifwG_klzDgPWFUgbok8dqx8HvsbezwD8LbURFpDlL6mic-XnMjd5unIt1gmqTI52wDsbXGqJ-fy-EJdbMB-fxemjQ8xbLixZrj5mhWcN6T_0HLzpSA9j1J9C25LHWo2vUby0-8zhFC1-QsC6SdREnRxhdiPZ6i6vhrdoJg3PSW3VvXcfL02s9k6m3XL0eF9uNfxSDFugX8AG1g_hDsn3Un5I_j2-bpaOj9JwVutVS2I6YmcubJoSnE0_fn9RxiLqr6sbMUZdwSxVyczuJ6z3HxmqK9ivmhooC6qxZ4YCyqfUW0Xa5VelldNf11TuGC1j-H88MPZ-4nf5Vnwc0nmsa8k0UJrYmlUqjDQFmM2bGKrONZPikh6akNjsEQdYG7CXJERiYmxYVgQpNET2KybGp-CGBUWFSKRPCxkVMo0zguiJIVUkURtUg9e9_87m7fhNLLeDCFQMgeKBzs9ElmnUYuMeI4mqpgG1MaroZh0gQ84TI3NimUkJ1OOtPRguwVu-Aq1y1nfIw-SNUgHAY6zvV5SV5cu3jbZYGlCRM-DNwP6_-r9Ozcu_i6RjY8P3MOz_xd9CVuTs5NpNj06_fgc7o44C7HzhNuBzeXVCneJGi3tC6cBvwDNywtB
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB6VIhUulDehBczjwCVVsrGTuOKyYlm1pVQIqNRLFdnJRA2skqibVUVP_AR-I7-kY-cBSwVC3BJ54sTOjP2NPf4G4EUeEmj1kbshDXwuN4ncdSpHrsY8lkKlxgcw0RYH4c4h3zsSRyvwqj8L0_JDDAtuxjLseG0MHOss_8XK1eeM7DyQ4RW4yoWMTUDf5MPo5x6CL9r8BR534yD2Ol4hE8czPLo8G12CmJcjJa8tylp9PVOz2TKatdPRdB2O-4a0UShfthaN3krPf-N4_N-W3oQbHU5l41axbsEKlrdh7V23E38Hzj-eFY2Nw2RmKbcoGSFJlhoszqqc7e7_-Pbdj1hRnhS6MBl9GKFjKzOEthu5eqaoL1g9r8gQ5sV8m40Zlc_oacvlSjfNadUfB2WWDPcuHE7ffHq943Z5HNyUk_vtCk6wU6uIKyEFeqHGyDhOkRaGS0gi0jigfaUwx9DDVPmpICcVY6V9PyOVCe7BalmV-ADYKNMoEAlEYsaDnMsozQjyZFwEHEMlHXjW_8-kbuk6kt7NoV5MbC86sNn_6aSz2HlCOCokKCo9quPpUEy2ZjZQVInVwshwk6w5CLkD91vFGN5C9Zqs8oED8ZLKDAKGx3u5pCxOLJ83-XgyJiDpwPNBu_729S-tsvxZIhnvTezFw38XfQJr7yfTZH_34O0GXB-ZJMc20G4TVpvTBT4i5NXox9bALgA3QStw
linkToUnpaywall http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjZ3NbtQwEIBHZSsBl_JbGlqQCxy4pNpsbCfubQVUpYIKCVYqp8hOJmpglay6WVXtqY_AM_IkjJ0fCBUVt0SeOBt7JvlmPZ4BeJVLgtYAuS_pxedzW8jdpGriG8xjJXRqfQAbbXEsD2f86EScrMFutxfmz_V7G3Gjv2VkzKGSt2BdCsLtEazPjj9NvzZYy_04dNXR3BqlxfE2e9Dg2uE35xpIXo-HvLMqF_riXM_nQ2Z1H52De7-37jSxJt_3VrXZSy__yuR44_Pch40WOdm00ZEHsIblQ7j9sV1UfwSXn8-L2oVUMvuvbFEygkKWWqxmVc7ef_h59SOIWFGeFqawxXkYga6T6aPUrdxirumB2WJZkU4vi-U-mzJqn9PVLi0rndRnVbezk7m8to9hdvDuy5tDvy3J4KecPGlfcCJIoyOuhRI4lgYjO-iRETYtkEIkkzaB1pijHGOqg1SQv4mxNkGQ0eyHmzAqqxK3gE0ygwKReBAzHuZcRWlG9JJxEXKUWnnwopu0ZNFk3kg6j4VGMXGj6MFON51Ja3zLhJBIElWqMfWx2zeT2di1EF1itbIy3NZdDiX34Ekz-_1dqF9bID70IB7oRS9gU3IPW8ri1KXmJndNxcSEHrzsVeimX__aKde_JZLp0Vt38PS_OtyGuxNbn9jFyO3AqD5b4TOCpto8b83mFyxgFFw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Switching+within+the+class+of+IL%E2%80%9017+inhibitors+for+the+treatment+of+plaque+psoriasis%3A+A+real%E2%80%90world+retrospective+study&rft.jtitle=Australasian+journal+of+dermatology&rft.au=Ioannis%E2%80%90Alexios+Koumprentziotis&rft.au=Rompoti%2C+Natalia&rft.au=Stefanaki%2C+Irene&rft.au=Vavouli%2C+Charitomeni&rft.date=2025-03-01&rft.pub=Wiley+Subscription+Services%2C+Inc&rft.issn=0004-8380&rft.eissn=1440-0960&rft.volume=66&rft.issue=2&rft.spage=101&rft.epage=104&rft_id=info:doi/10.1111%2Fajd.14396&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0004-8380&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0004-8380&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0004-8380&client=summon